The Open Targets Initiative Brings Scientists Closer to Identifying the Cause of Autoimmune Diseases

  Scientists believe that “it is in our DNA.” According to a recent article in EurekAlert, a five-year study formulated through Open Targets together with the Sanger Institute and their…

Continue Reading The Open Targets Initiative Brings Scientists Closer to Identifying the Cause of Autoimmune Diseases

Patients Recruited for Phase 2 Study of Experimental Friedreich’s Ataxia Treatment

According to a press release from Barcelona-based biotechnology company Minoryx Therapeutics, the Company has completed enrollment for a phase 2 clinical study of its experimental Friedreich's ataxia treatment, MIN-102 (generic…

Continue Reading Patients Recruited for Phase 2 Study of Experimental Friedreich’s Ataxia Treatment
Experimental Non-Steroid Treatment Displays Potential for Congenital Adrenal Hyperplasia
Anqa / Pixabay

Experimental Non-Steroid Treatment Displays Potential for Congenital Adrenal Hyperplasia

According to a story from Healio, the results from a recent phase 2A clinical trial have demonstrated the effectiveness of an experimental drug in treating congenital adrenal hyperplasia (CAH). The…

Continue Reading Experimental Non-Steroid Treatment Displays Potential for Congenital Adrenal Hyperplasia

A Girl Diagnosed with Batten Disease got Treated with a Drug Developed Specifically for Her

According to a story from Technology Review, the story of Mila Makovec shows the potential impact that personalized medicine could have on patients while also revealing some of its limitations.…

Continue Reading A Girl Diagnosed with Batten Disease got Treated with a Drug Developed Specifically for Her
Close Menu